| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Hilzinger Kurt J is a Director at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 17 buys and 0 sells.
Estimated insider holdings value: $669K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 3,100 | $0.69 | $2,131.00 | +1.4% | |
| Jan 15, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 6,665 | $0.71 | $4,709.49 | +3.1% | |
| Jan 10, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 8,845 | $0.71 | $6,275.26 | +4.5% | |
| Jan 8, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 17,781 | $0.62 | $11,082.03 | +7.1% | |
| Jan 3, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 17,189 | $0.59 | $10,141.51 | +8.3% | |
| Dec 28, 2018 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 18,354 | $0.53 | $9,651.06 | +13.1% | |
| Dec 24, 2018 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 4,713 | $0.65 | $3,074.58 | +6.0% |